A REVOLUTIONARY NEW THERAPY THAT USES TARGETED ELECTRIC PULSES TO RESET AND RESTORE
SETPOINT BIOELECTRONIC MEDICINE THERAPY PLATFORM IS AN ENTIRELY NEW APPROACH TO TREAT DISEASE AT THE SOURCE
The SetPoint Medical bioelectronic medicine platform delivers targeted electrical pulses to trigger the intrinsic inflammatory reflex. This pathway shows promise as an alternative, efficient treatment option for rheumatoid arthritis (RA), Crohn’s disease, and other chronic autoimmune diseases – that may reduce risk, lower cost and improve patient adherence to therapy.
THREE COMPONENTS, ONE INTEGRATED PLATFORM
SetPoint Medical’s novel, proprietary bioelectronic platform consists of an implantable MicroRegulator, a wireless charging collar or band and iPad-based prescription application.
SetPoint Medical’s miniaturized therapeutic device activates an innate pathway, the inflammatory reflex, to restore balance to the immune system.
CLINICAL STUDIES IN RHEUMATOID ARTHRITIS AND CROHN'S DISEASE ONGOING, WITH ROBUST PIPELINE TO FOLLOW
Bioelectronic medicine provides an alternative treatment option for a range of autoimmune conditions without the significant side effects of immunosuppression typically associated with conventional therapies.
SetPoint Medical has focused this new therapeutic approach for debilitating conditions starting with rheumatoid arthritis (RA) with the opportunity to expand into other autoimmune indications such as inflammatory bowel disease and multiple sclerosis.
THE PATIENT EXPERIENCE
Bioelectronic medicine to treat chronic autoimmune diseases has already undergone initial proof-of-concept clinical studies using
an off-the-shelf vagus nerve stimulator.
INVESTIGATIONAL DEVICE DISCLAIMER: The SetPoint Medical device is an investigational device. It is currently undergoing clinical evaluation under Food and Drug Administration’s Investigational Device Exemption and is not approved for commercial use.